Form 4: OPKO Health Director Krasno Reports Stock Option Grant

Richard M. Krasno, a director at OPKO Health, Inc., reported the acquisition of a stock option for 30,000 shares of common stock.

Summary

• Richard M. Krasno, a director of OPKO Health, Inc., filed a Form 4 with the SEC.
• The filing reports a transaction that occurred on March 28, 2024.
• Krasno acquired a stock option (right to buy) for 30,000 shares of OPKO Health's common stock.
• The exercise price of the option is $1.20.
• The option becomes exercisable on March 28, 2025, and expires on March 27, 2034.
• Following the reported transaction, Krasno directly owns the derivative securities.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't inherently indicate positive or negative sentiment, but rather reports a transaction.

Positives

• The grant of stock options to a director can align their interests with those of shareholders, incentivizing them to work towards increasing the company's stock value.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The granting of stock options is a common practice to incentivize directors and management.

Stakeholder Impact

• The stock option grant could potentially benefit shareholders if the director's efforts lead to an increase in the company's stock price.

Key Dates